Prime Medicine, Inc. - 8-K Filing
On June 5, 2026, Prime Medicine held its annual stockholder meeting and elected Michael Kelly and David Schenkein as Class I Directors with vote totals of 107.0 million for (3.0 million withheld) and 87.5 million for (2.6 million withheld), respectively. Stockholders also ratified the appointment of PricewaterhouseCoopers LLP as auditors, receiving 139.9 million votes in favor with minimal opposition. (Items: 5.07 Submission of Matters to a Vote of Security Holders)
Tickers: $PRME